CHAPEL HILL, N.C.--(BUSINESS WIRE)--
POZEN Inc. (NASDAQ:POZN), announced today that it will release
third quarter 2008 results on October 29, 2008, before the market
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time with a discussion by POZEN management of the earnings and
business results. The webcast can be accessed on POZEN's website at
www.pozen.com and will be archived and available for replay. The third
quarter 2008 earnings release will be accessible in the News section
of POZEN's website.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN's
efforts are focused primarily on the development of pharmaceutical
products for the treatment of acute and chronic pain and other
pain-related conditions. POZEN has development and commercialization
alliances with GlaxoSmithKline for Treximet(R), which was approved by
the United States Food and Drug Administration for the acute treatment
of migraine attacks; and with AstraZeneca for proprietary fixed dose
combinations of naproxen with the proton pump inhibitor esomeprazole
magnesium in a single tablet for conditions such as osteoarthritis and
rheumatoid arthritis in patients who are at risk for developing
NSAID-associated gastric ulcers. The company's common stock is traded
on The Nasdaq Stock Market under the symbol "POZN". For detailed
company information, including copies of this and other press
releases, see POZEN's website: www.pozen.com.
Source: POZEN Inc.